Clinical Research Management Briefing - May 29, 2018
Under the legislation, patients with terminal conditions will be able to bypass the Food and Drug Administration (FDA) to access experimental drug treatments.
The New York Times, May 22
Gathering and deciphering medical records are some of the biggest barriers in one organization’s quest to create a database that links cancer treatment outcomes with medical information.
The New York Times, May 21
The hope that gene therapy will change how illnesses get treated will be tested as the FDA announces a new policy.
STAT, May 22
Financial and Operations
With its reputation on the line, the National Institutes of Health (NIH) stopped enrollment until a thorough review of the study and its funding is completed.
STAT, May 17
Patients are on board with their health data being collected – it’s the doctors and medical industry that need convincing.
MM&M, May 16
Pharm and Biotech
The complexity of Alzheimer’s is causing major setbacks to pharmaceutical companies who are conducting research – all at a time when the number of older adults in the United States grows.
Quartz, May 20
Higher education and independent research institutions are benefiting by migrating their administrative software to cloud-based systems.
In less than a year, Colorado State University (CSU) reduced its number of certifications per quarter by more than 1,000 with Huron’s Employee Compensation Compliance solution.